Stephen Klautky is a Cardiology physician affiliated with Summa Health System. OpenAlex indexes 11 publications with 376 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
185 W Cedar St
Suite 100
Akron, OH 443072400
Telephone
330-376-0500Registry record last updated 11 Apr 2011.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.9%Beta blocker18.5%Metoprolol Succinate48%Metoprolol Tartrate29%Carvedilol23%Part D≥40 patientsStatin14.2%Atorvastatin Calcium64%Rosuvastatin Calcium37%Part D≥53 patients+ 15 more classes in this area
Blood & clotting
14.2%Factor Xa inhibitor10.5%Eliquis83%Xarelto17%Part D<11 patientsP2Y12 inhibitor3.8%Clopidogrel76%Brilinta24%Part D<11 patientsMetabolism & gastrointestinal
8.9%SGLT2 inhibitor7.5%Farxiga58%Jardiance42%Part D≥20 patientsPotassium supplement1.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-17834-ACC A DEADLY CASCADE: CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WITH MYOCARDIAL INFARCTION, LEFT VENTRICULAR THROMBUS, AND MULTI-VESSEL THROMBOSIS
Journal of the American College of Cardiology
2026 - Cyclic AMP-mediated Inhibition of Transcription of the Malic Enzyme Gene in Chick Embryo Hepatocytes in Culture
Journal of Biological Chemistry
1997 - Nutritional and Hormonal Regulation of Expression of the Gene for Malic Enzyme
Progress in nucleic acid research and molecular biology
1996
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas File, MD
Summa Health System
Marc Penn, MD
Summa Health System
Drazen Petrinec, MD
Summa Health System
Sameer Mahesh, MD
Summa Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”